Literature DB >> 9334215

Turnover of the acyl phosphates of human and murine prothymosin alpha in vivo.

R H Wang1, L Tao, M W Trumbore, S L Berger.   

Abstract

Prothymosin alpha is a small, highly acidic, abundant, nuclear, mammalian protein which is essential for cell growth. Our laboratory has recently shown that primate prothymosin alpha contains stoichiometric amounts of phosphate on the glutamyl groups of the protein and that in vitro the phosphate undergoes rapid hydrolysis or transfer to a nearby serine residue. Here an assay for the presence of acyl phosphates in vivo has been developed by measuring stable phosphoserine and phosphothreonine in vitro. The assay was used to determine the half-life of the acyl phosphates on prothymosin alpha in vivo by pulse-labeling HeLa cells with [32P]orthophosphate and chasing using three different techniques: permeabilization with digitonin to allow extracellular ATP to equilibrate with the intracellular pool; electroporation in the presence of ATP to reduce the specific activity of [32P]ATP by expansion of the pool; and incubation with inorganic phosphate. Regardless of the method, the phosphate turned over with a half-life of 75-90 min. The ability of cells to phosphorylate old prothymosin alpha molecules was established by demonstrating equivalent labeling of the protein with [32P]orthophosphate in the presence and absence of cycloheximide. The half-life of the acyl phosphates was also studied in resting and growing NIH3T3 cells, with measured values of 30-35 and 70 min, respectively. Our data suggest that the "activity" of prothymosin alpha involves the turnover of its acyl phosphates and that it participates in a function common to all nucleated mammalian cells regardless of whether they are quiescent or undergoing rapid proliferation. This is the first measurement of the stability of protein-bound acyl phosphates in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9334215     DOI: 10.1074/jbc.272.42.26405

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Properties of the protein kinase that phosphorylates prothymosin alpha.

Authors:  A Peréz-Estévez; J Freire; C Sarandeses; G Covelo; C Díaz-Jullien; M Freire
Journal:  Mol Cell Biochem       Date:  2000-05       Impact factor: 3.396

2.  Prothymosin alpha selectively enhances estrogen receptor transcriptional activity by interacting with a repressor of estrogen receptor activity.

Authors:  P G Martini; R Delage-Mourroux; D M Kraichely; B S Katzenellenbogen
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

Review 3.  Redox Signaling by Reactive Electrophiles and Oxidants.

Authors:  Saba Parvez; Marcus J C Long; Jesse R Poganik; Yimon Aye
Journal:  Chem Rev       Date:  2018-08-27       Impact factor: 60.622

4.  Prothymosin alpha is a chromatin-remodelling protein in mammalian cells.

Authors:  J Gomez-Marquez; P Rodríguez
Journal:  Biochem J       Date:  1998-07-01       Impact factor: 3.857

5.  Mitochondrial variability as a source of extrinsic cellular noise.

Authors:  Iain G Johnston; Bernadett Gaal; Ricardo Pires das Neves; Tariq Enver; Francisco J Iborra; Nick S Jones
Journal:  PLoS Comput Biol       Date:  2012-03-08       Impact factor: 4.475

6.  AZT resistance alters enzymatic properties and creates an ATP-binding site in SFVmac reverse transcriptase.

Authors:  Anna Schneider; Kristian Schweimer; Paul Rösch; Birgitta M Wöhrl
Journal:  Retrovirology       Date:  2015-02-22       Impact factor: 4.602

7.  ZINC40099027 activates human focal adhesion kinase by accelerating the enzymatic activity of the FAK kinase domain.

Authors:  Shyam K More; Qinggang Wang; Emilie E Vomhof-DeKrey; James E Porter; Marc D Basson
Journal:  Pharmacol Res Perspect       Date:  2021-04

8.  IRBIT Interacts with the Catalytic Core of Phosphatidylinositol Phosphate Kinase Type Iα and IIα through Conserved Catalytic Aspartate Residues.

Authors:  Hideaki Ando; Matsumi Hirose; Laura Gainche; Katsuhiro Kawaai; Benjamin Bonneau; Takeshi Ijuin; Toshiki Itoh; Tadaomi Takenawa; Katsuhiko Mikoshiba
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.